MARKET

GMED

GMED

Globus Medical
NYSE

Real-time Quotes | Nasdaq Last Sale

63.40
-1.79
-2.75%
Opening 15:20 01/27 EST
OPEN
65.69
PREV CLOSE
65.19
HIGH
65.94
LOW
63.12
VOLUME
744.30K
TURNOVER
--
52 WEEK HIGH
84.23
52 WEEK LOW
59.37
MARKET CAP
6.43B
P/E (TTM)
34.87
1D
5D
1M
3M
1Y
5Y
Edwards Lifesciences (EW) Lags Q4 Earnings and Revenue Estimates
Edwards Lifesciences (EW) delivered earnings and revenue surprises of -7.27% and 1.03%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 21h ago
UBS maintains buy for Globus Medical on survey indicating market share growth
UBS is maintaining its buy rating on Globus Medical (NYSE:GMED) citing a survey of spine and neurosurgeons indicating it is poised to gain the most market share among competitors. Analyst
Seekingalpha · 1d ago
At US$65.87, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List?
Globus Medical, Inc. ( NYSE:GMED ), might not be a large cap stock, but it received a lot of attention from a...
Simply Wall St. · 1d ago
Encompass Health (EHC) to Spin Off Home Health & Hospice Unit
Encompass Health (EHC) expects the Enhabit Home Health & Hospice spinoff to be completed in first-half 2022.
Zacks · 01/20 16:26
Ensign Group (ENSG) Up 7.4% in 3 Months: More Growth Ahead?
Ensign Group (ENSG) is likely to keep growing on the back of Skilled services and impressive financial strength.
Zacks · 01/19 16:56
Molina Healthcare (MOH) Up 14.4% in 6 Months: Growth Ahead?
Molina Healthcare (MOH) is likely to keep growing on the back of increasing membership and higher premium revenues.
Zacks · 01/18 15:19
Select Medical (SEM) '21 Sales View Up, Labor Costs Ail Profits
Select Medical Holdings (SEM) estimates net operating revenues for 2021 to be $6.2 billion, up from the previous expectations.
Zacks · 01/18 14:06
Next Capital Management LLC Buys Globus Medical Inc, Tesla Inc, PPG Industries Inc, Sells Apple ...
Investment company Next Capital Management LLC (Current Portfolio) buys Globus Medical Inc, Tesla Inc, PPG Industries Inc, CSG Systems International Inc, iShares Core MSCI Emerging Markets ETF, sells Apple Inc, Nuveen Floating Rate Income Fund, Blackrock F...
GuruFocus.com · 01/14 18:38
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GMED. Analyze the recent business situations of Globus Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

18.75%Strong Buy
50.00%Buy
25.00%Hold
6.25%Under-perform
0.00%Sell
Analyst Price Target
The average GMED stock price target is 86.93 with a high estimate of 100.00 and a low estimate of 72.00.
High100.00
Average86.93
Low72.00
Current 63.24
EPS
Actual
Estimate
0.140.290.430.58
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 445
Institutional Holdings: 71.71M
% Owned: 70.67%
Shares Outstanding: 101.47M
TypeInstitutionsShares
Increased
134
2.59M
New
64
2.19M
Decreased
110
3.55M
Sold Out
26
648.89K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.88%
Healthcare Equipment & Supplies
-0.94%
Key Executives
Chairman/Executive Director
David Paul
President/Chief Executive Officer/Director
David Demski
Chief Financial Officer/Senior Vice President
Keith Pfeil
Executive Vice President/IR Contact Officer
Daniel Scavilla
Senior Vice President/General Counsel/Secretary
Kelly Huller
Independent Director
David Davidar
Independent Director
Robert Douglas
Independent Director
Daniel Lemaitre
Independent Director
Ann Rhoads
Independent Director
James Tobin
Independent Director
Stephen Zarrilli
No Data
About GMED
Globus Medical, Inc. is a medical device company. The Company is primarily focused on implants that promote healing in patients with musculoskeletal disorders. The Company group its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are computer-assisted intelligent systems designed to improve a surgeon’s capabilities, and ultimately improve patient care and reduce radiation exposure for all involved. Its INR solutions include the ExcelsiusGPS platform, which is a robotic guidance and navigation system that supports minimally invasive and open procedures with screw and interbody spacer placement applications.

Webull offers kinds of Globus Medical Inc stock information, including NYSE:GMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GMED stock methods without spending real money on the virtual paper trading platform.